Indication
Esophageal and Gastric Cancers (EGC)
1 clinical trial
1 product
Clinical trial
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)Status: Completed, Estimated PCD: 2023-02-24
Product
Pembrolizumab